Why some family offices are becoming cancer research’s new bankrollers

March 13, 2026 | Marcus Baram

Family offices are stepping in to fill a widening gap in cancer research funding, deploying billions of dollars of patient capital at a moment when federal cuts threaten to stall laboratories and AI breakthroughs promise to accelerate drug development.

Read More at Crain Currency.

UPDATES AND NEWS

Media Coverage

We can prevent ovarian cancer. Women deserve the option. | USA Today

Media Coverage

Fallopian tube removal may lower ovarian cancer risk | Good Morning America

Press Release

The Lustgarten Foundation and Break Through Cancer Announce New Clinical Trial Evaluating KRAS-targeted Immunotherapy Strategy for Pancreatic Cancer

Media Coverage

Most ‘Ovarian Cancer’ Isn’t. And That Fact Can Save Lives | New York Times

View All

BE PART OF THE MISSION
Stay Informed, Make an Impact

Subscribe

Be the first to hear about cutting-edge research, pioneering projects, and the latest advancements in Break Through Cancer science. Sign up to stay informed.

* indicates required
Email Format

Give

Your contribution fuels groundbreaking research in some of the most challenging cancers. Every gift accelerates progress. For more information please contact Michaela Forand at MF@breakthroughcancer.org or 1-800-757-9881 ext 2.

Media Coverage
6 likes